CIK 0001590560
- Large accelerated filer
uniQure N.V.
Sign in to watch- Ticker
- QURE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 339-970-7000
- Business address
- PAASHEUVELWEG 25A, AMSTERDAM, Netherlands, 1105 BP
- Former names
- uniQure B.V.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $192,950
- in 1 filing, $193K under 10b5-1 plans
Net −$192,950. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-19 | POST LEONARD E Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-19 | Jacques Rachelle Suzanne Director | Grant or award | +8,080 | 22,488 | ||
| 2024-06-19 | Jacques Rachelle Suzanne Director | Grant or award · Stock Option (Right to Buy) | +15,840 | 15,840 | ||
| 2024-06-17 | CALOZ PIERRE Chief Operating Officer | Sale | −2,936 | $4.81 | $14K | 115,707 |
| 2024-06-17 | KLEMT CHRISTIAN Chief Financial Officer | Sale | −1,611 | $4.80 | $8K | 164,837 |
| 2024-06-13 | POST LEONARD E Director | Sale | −2,222 | $5.14 | $11K | 15,999 |
| 2024-06-13 | Potts Jeannette Chief Legal Officer | Sale | −4,781 | $4.98 | $24K | 91,819 |
| 2024-06-13 | Springhorn Jeremy P. Director | Sale | −2,231 | $5.12 | $11K | 23,756 |
| 2024-06-13 | Meek David D. Director | Sale | −2,229 | $5.12 | $11K | 20,252 |
| 2024-06-13 | Balachandran Madhavan Director | Sale | −2,231 | $5.12 | $11K | 23,759 |
| 2024-06-13 | Soteropoulos Paula Director | Sale | −2,220 | $5.14 | $11K | 20,203 |
| 2024-06-13 | Gut Robert Director | Sale | −3,504 | $5.12 | $18K | 44,165 |
| 2024-06-13 | Kaye Jack Director | Sale | −2,218 | $5.16 | $11K | 6,501 |
| 2024-06-13 | Jacques Rachelle Suzanne Director | Sale | −2,221 | $5.14 | $11K | 14,408 |
| 2024-03-01 | Kapusta Matthew C CEO, Managing Director | Grant or award | +150,000 | 590,839 | ||
| 2024-03-01 | Kapusta Matthew C CEO, Managing Director | Grant or award · Stock Option (Right to Buy) | +259,500 | 259,500 | ||
| 2024-03-01 | KLEMT CHRISTIAN Chief Financial Officer | Grant or award | +49,500 | 166,448 | ||
| 2024-03-01 | KLEMT CHRISTIAN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +85,500 | 85,500 | ||
| 2024-03-01 | Abi-Saab Walid Chief Medical Officer | Grant or award | +49,500 | 116,700 | ||
| 2024-03-01 | Abi-Saab Walid Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +85,500 | 85,500 |
Page 11 of 13 · 251 trades